BACKGROUND: @entity6887 ( @entity6887 ) is rarely seen clinically. Herein, we investigate the clinical and pathological characteristics and appropriate therapies for @entity6887 . METHODS: A total of 36 @entity1 for whom @entity6887 was pathologically confirmed from January 2001 to July 2011 in Beijing Hospital of Gynecology and Obstetrics, an affiliate of Capital Medical University, were retrospectively analyzed. RESULTS: A total of 36 cases underwent surgical staging in our hospital: 47.2% were early stage cases , and 52.8% were advanced stage cases. Of the 36 cases, 24 cases were pure @entity420 , 10 cases were mixed, and there was 1 case of @entity189 , 1 case of @entity189 combined with transitional cell @entity189 , 5 cases of moderately differentiated @entity189 , and 29 cases of moderately to poorly differentiated @entity189 . There were no cases of highly differentiated @entity189 . Among the cases examined, 38.9% (14/36) had omentum @entity3 , and 19 cases had an elevated @entity10224 during a preoperative biochemical laboratory test. Approximately 35 cases received postoperative adjuvant chemotherapy. The 3-year and 5-year overall survival rates for the 36 cases were 80.7% and 65.4%, respectively. Single-factor analysis showed that the pathological conditions of @entity41 diameter >1 cm (P < 0.001), omentum @entity3 (P = 0.003), ovary @entity3 (P = 0.004) and elevated preoperative @entity10224 (P = 0.044) were associated with prognosis, whereas pathological surgical staging (P = 0.069), retroperitoneal lymph node @entity3 (P = 0.499), and pathological classification (P = 0.183) were not associated with prognosis. Multifactor analysis showed that a @entity41 diameter >1 cm (P = 0.019) and omentum @entity3 (P = 0.015) were associated with prognosis, and were, therefore, the independent risk factors of prognosis. CONCLUSIONS: @entity6887 is a rare female genital tract malignancy. Most @entity1 are in an advanced stage at diagnosis, which results in a poor prognosis. Complete surgical staging and maximal resection should be recommended.

Clinical and survival analysis of 36 cases of XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity41 :: ('MESH:D018365', 'Disease') :: ['residual tumor'] @entity6887 :: ('MESH:D005185', 'Disease') :: ['Primary fallopian tube carcinoma', 'PFTC'] @entity189 :: ('MESH:D002277', 'Disease') :: ['carcinoma', 'undifferentiated carcinoma'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastasis'] @entity10224 :: ('94025', 'Gene') :: ['CA125'] @entity420 :: ('MESH:D000230', 'Disease') :: ['adenocarcinoma']
@entity6887 :: (MESH:D005185,Disease) :: ['primary fallopian tube carcinoma']
